Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation.

Kurtz DM, Rinaldo P, Rhead WJ, Tian L, Millington DS, Vockley J, Hamm DA, Brix AE, Lindsey JR, Pinkert CA, O'Brien WE, Wood PA.

Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15592-7.

2.

Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.

Cox KB, Hamm DA, Millington DS, Matern D, Vockley J, Rinaldo P, Pinkert CA, Rhead WJ, Lindsey JR, Wood PA.

Hum Mol Genet. 2001 Sep 15;10(19):2069-77.

3.
4.
5.

Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation.

Schuler AM, Gower BA, Matern D, Rinaldo P, Vockley J, Wood PA.

Mol Genet Metab. 2005 May;85(1):7-11. Epub 2005 Feb 16.

PMID:
15862275
6.

Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse.

Bakermans AJ, Dodd MS, Nicolay K, Prompers JJ, Tyler DJ, Houten SM.

Cardiovasc Res. 2013 Dec 1;100(3):441-9. doi: 10.1093/cvr/cvt212. Epub 2013 Sep 16.

7.
8.

Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function.

Bakermans AJ, Geraedts TR, van Weeghel M, Denis S, João Ferraz M, Aerts JM, Aten J, Nicolay K, Houten SM, Prompers JJ.

Circ Cardiovasc Imaging. 2011 Sep;4(5):558-65. doi: 10.1161/CIRCIMAGING.111.963751. Epub 2011 Jul 7.

9.
11.
12.

Human long chain, very long chain and medium chain acyl-CoA dehydrogenases are specific for the S-enantiomer of 2- methylpentadecanoyl-CoA.

Battaile KP, McBurney M, Van Veldhoven PP, Vockley J.

Biochim Biophys Acta. 1998 Feb 23;1390(3):333-8.

PMID:
9487154
13.

Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction.

Goetzman ES, Alcorn JF, Bharathi SS, Uppala R, McHugh KJ, Kosmider B, Chen R, Zuo YY, Beck ME, McKinney RW, Skilling H, Suhrie KR, Karunanidhi A, Yeasted R, Otsubo C, Ellis B, Tyurina YY, Kagan VE, Mallampalli RK, Vockley J.

J Biol Chem. 2014 Apr 11;289(15):10668-79. doi: 10.1074/jbc.M113.540260. Epub 2014 Mar 3.

14.

Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids.

Lea W, Abbas AS, Sprecher H, Vockley J, Schulz H.

Biochim Biophys Acta. 2000 May 31;1485(2-3):121-8.

PMID:
10832093
15.
16.

Mouse models for disorders of mitochondrial fatty acid beta-oxidation.

Schuler AM, Wood PA.

ILAR J. 2002;43(2):57-65. Review.

17.

Low expression of long-chain acyl-CoA dehydrogenase in human skeletal muscle.

Maher AC, Mohsen AW, Vockley J, Tarnopolsky MA.

Mol Genet Metab. 2010 Jun;100(2):163-7. doi: 10.1016/j.ymgme.2010.03.011. Epub 2010 Mar 19.

18.

Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.

Djouadi F, Aubey F, Schlemmer D, Ruiter JP, Wanders RJ, Strauss AW, Bastin J.

Hum Mol Genet. 2005 Sep 15;14(18):2695-703. Epub 2005 Aug 22.

19.

Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects.

Houten SM, Herrema H, Te Brinke H, Denis S, Ruiter JP, van Dijk TH, Argmann CA, Ottenhoff R, Müller M, Groen AK, Kuipers F, Reijngoud DJ, Wanders RJ.

Hum Mol Genet. 2013 Dec 20;22(25):5249-61. doi: 10.1093/hmg/ddt382. Epub 2013 Aug 9.

20.
Items per page

Supplemental Content

Write to the Help Desk